Windtree Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree's proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies…More being developed to enable noninvasive administration of aerosolized KL4 surfactant.
Social Media Links
REPORT RATINGS
4.7 / 5.0 (72)
Windtree Therapeutics, Inc. reports have an aggregate usefulness score of 4.7 based on 72 reviews.